Neurological Disorder Diagnostics Market : Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Neurological Disorder Diagnostics Market: By Component (Instruments, Reagents and Kits, Software and Services), By Technology (Immunoassay, PCR Techniques), By Disease Type (Alzheimer’s Disea, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Others), By End User (Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes),

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global neurological disorder diagnostics market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 owing to increasing prevalence of neurological problems that are caused by genetic disorders, congenital abnormalities, infections, lifestyle, environmental health problems including malnutrition, and brain injury, spinal cord injury etc. and launch of innovative products for diagnosis of disease and approvals for novel diagnostic products for neurological disorders are the major factors that are driving the growth of the neurological disorder diagnostics market. Moreover, rising adoption of biomarkers to diagnose various diseases fuels the growth of the market over the forecasted period. However, high cost of neurological diagnostic imaging tools such as MRI and CT scan are expected to restrain the growth of the market over the future years.Global neurological disorder diagnostics market is surging owing to product launches and approvals of novel neurological disorder by the market players and strategic collaborations and acquisitions among them to strengthen their position in the market. For instance, in April 2018, Canon Medical Systems Corporation launched 1.5T MRI System, Vantage Orian. In 2017, Neusoft Medical Systems received U.S. FDA approval for NeuViz Prime CT Scanner. In April 2018, Siemens Healthineers received U.S. FDA approval for its new SOMATOM go.All and SOMATOM go.Top computed tomography (CT) systems. This report gives comprehensive outlook on neurological disorder diagnostics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of technology, indication, end user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global neurological disorder diagnostics market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global neurological disorder diagnostics market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global neurological disorder diagnostics market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global neurological disorder diagnostics products.


Neurological Disorder Diagnostics Market

MARKET SUMMARY
-
% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– %
  • Largest Market– North America
  • Fastest Growing Market– Europe

Neurological Disorder Diagnostics Market

  • Global neurological disorder diagnostics market expanding at significant CAGR over 2022 to 2028 owing to increasing prevalence of neurological disorders and rising adoption of new technologies
  • Based on technology, CT scan market accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global neurological disorder diagnostics market
Market Key Players
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • General Electric Company
  • Esaote SpA
  • NeuroLogica Corporation
  • Masimo Corporation
Drivers And Restraints

Neurological Disorder Diagnostics Market

Currently, adoption of new technology among the population has been increased in past few decades. Additionally, market players are focusing on the development of novel technologies for neurological disorders to offer the advanced treatment options. For instance, For instance, Canon Medical Systems, Kumamoto University, and University of Bordeaux entered into collaborative research for the development of deep learning technology in magnetic resonance imaging. Increase in per capita healthcare expenditure and well develop healthcare infrastructure boosts the growth of the market over the forecast period.


North-America got significant share

Neurological Disorder Diagnostics Market

North America accounted for larger revenue share in global neurological disorder diagnostics market with significant CAGR and is expected to grow over the forecast years owing to technological advancements in the region and presence of large number of market players and development and launch of new products enhances the growth of the market. Moreover, availability of healthcare reimbursements and well established healthcare infrastructure in the region drives the growth of the market. Europe and Asia Pacific market expected to grow at a faster growth rate owing to owing to increasing prevalence of neurological disorders in the region and rising awareness among the people about the availability of advanced medical treatments and improving healthcare infrastructure in the emerging countries of the region. Additionally, rising adoption of diagnostic devices by the hospitals and ambulatory surgical centers. For instance, Japan have over 100 CT scanners per 1,000,000 population. According to OECD, Japan had 107.2 CT scanners per 1,000,000 population in 2014.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Neurological Disorder Diagnostics Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Neurological Disorder Diagnostics Market Introduction
2.1. Global Neurological Disorder Diagnostics Market – Taxonomy
2.2. Global Neurological Disorder Diagnostics Market –Definitions
2.2.1. By Component
2.2.2. By Technology
2.2.3. By Disease Type
2.2.4. By End User
2.2.5. By Region
3. Global Neurological Disorder Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Neurological Disorder Diagnostics Market Dynamic Factors – Impact Analysis
3.6. Global Neurological Disorder Diagnostics Market – Competition Landscape
3.7. Epidemiology
4. Global Neurological Disorder Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Neurological Disorder Diagnostics Market, By Component, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents and Kits
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Neurological Disorder Diagnostics Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Immunoassay
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. PCR Techniques
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Neurological Disorder Diagnostics Market, By Disease Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Alzheimers Disease
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dementia
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Parkinson’s Disease
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Epilepsy
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Traumatic Brain Injury
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Neurological Disorder Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospitals and Clinics
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Diagnostic Centers
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Research Institutes
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Component, By Technology, By Disease Type, By End User, and Region, 2022-2028
10. North America Neurological Disorder Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.2. Reagents and Kits
10.1.3. Software and Services
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Immunoassay
10.2.2. PCR Techniques
10.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Alzheimers Disease
10.3.2. Dementia
10.3.3. Parkinson’s Disease
10.3.4. Epilepsy
10.3.5. Traumatic Brain Injury
10.3.6. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals and Clinics
10.4.2. Diagnostic Centers
10.4.3. Academic and Research Institutes
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2022-2028
10.7. North America Neurological Disorder Diagnostics Market Dynamics – Trends
11. Europe Neurological Disorder Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.2. Reagents and Kits
11.1.3. Software and Services
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Immunoassay
11.2.2. PCR Techniques
11.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Alzheimers Disease
11.3.2. Dementia
11.3.3. Parkinson’s Disease
11.3.4. Epilepsy
11.3.5. Traumatic Brain Injury
11.3.6. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals and Clinics
11.4.2. Diagnostic Centers
11.4.3. Academic and Research Institutes
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2022-2028
11.7. Europe Neurological Disorder Diagnostics Market Dynamics – Trends
12. Asia-Pacific Neurological Disorder Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.2. Reagents and Kits
12.1.3. Software and Services
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Immunoassay
12.2.2. PCR Techniques
12.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Alzheimers Disease
12.3.2. Dementia
12.3.3. Parkinson’s Disease
12.3.4. Epilepsy
12.3.5. Traumatic Brain Injury
12.3.6. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals and Clinics
12.4.2. Diagnostic Centers
12.4.3. Academic and Research Institutes
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Component, By Capacity, by Disease Type, By End User, and Country, 2022-2028
12.7. Asia-Pacific Neurological Disorder Diagnostics Market Dynamics – Trends
13. Latin America Neurological Disorder Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.2. Reagents and Kits
13.1.3. Software and Services
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Immunoassay
13.2.2. PCR Techniques
13.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Alzheimers Disease
13.3.2. Dementia
13.3.3. Parkinson’s Disease
13.3.4. Epilepsy
13.3.5. Traumatic Brain Injury
13.3.6. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals and Clinics
13.4.2. Diagnostic Centers
13.4.3. Academic and Research Institutes
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2022-2028
13.7. Latin America Neurological Disorder Diagnostics Market Dynamics – Trends
14. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.2. Reagents and Kits
14.1.3. Software and Services
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Immunoassay
14.2.2. PCR Techniques
14.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Alzheimers Disease
14.3.2. Dementia
14.3.3. Parkinson’s Disease
14.3.4. Epilepsy
14.3.5. Traumatic Brain Injury
14.3.6. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals and Clinics
14.4.2. Diagnostic Centers
14.4.3. Academic and Research Institutes
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoEnd User Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2022-2028
14.7. MEA Neurological Disorder Diagnostics Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis)
15.2.1. F. Hoffmann La Roche Ltd.
15.2.2. Creative Biolabs
15.2.3. Diadem Srl
15.2.4. Fujirebio Diagnostics
15.2.5. Quest Diagnostics
15.2.6. Thermo Fisher Scientific, Inc.
15.2.7. Bio-Rad Laboratories, Inc.
15.2.8. Siemens Healthineers
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Hoffmann La Roche Ltd.
  •  Creative Biolabs
  •  Diadem Srl
  •  Fujirebio Diagnostics
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers

Description

The global neurological disorder diagnostics market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 owing to increasing prevalence of neurological problems that are caused by genetic disorders, congenital abnormalities, infections, lifestyle, environmental health problems including malnutrition, and brain injury, spinal cord injury etc. and launch of innovative products for diagnosis of disease and approvals for novel diagnostic products for neurological disorders are the major factors that are driving the growth of the neurological disorder diagnostics market. Moreover, rising adoption of biomarkers to diagnose various diseases fuels the growth of the market over the forecasted period. However, high cost of neurological diagnostic imaging tools such as MRI and CT scan are expected to restrain the growth of the market over the future years.Global neurological disorder diagnostics market is surging owing to product launches and approvals of novel neurological disorder by the market players and strategic collaborations and acquisitions among them to strengthen their position in the market. For instance, in April 2018, Canon Medical Systems Corporation launched 1.5T MRI System, Vantage Orian. In 2017, Neusoft Medical Systems received U.S. FDA approval for NeuViz Prime CT Scanner. In April 2018, Siemens Healthineers received U.S. FDA approval for its new SOMATOM go.All and SOMATOM go.Top computed tomography (CT) systems. This report gives comprehensive outlook on neurological disorder diagnostics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of technology, indication, end user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global neurological disorder diagnostics market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global neurological disorder diagnostics market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global neurological disorder diagnostics market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global neurological disorder diagnostics products.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX